Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million.
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Quantum Genomics and its partners reach a new stage of development in Asia The phase III REFRESH study has been approved by the regulatory authorities and ethics committees in South Korea and Taiwan. Pre-marketing
Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting Firibastat is as efficent as the current standard of care
zonebourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zonebourse.com Daily Mail and Mail on Sunday newspapers.